About tazobacta m + vial
Cephalosporin antibiotic plus beta-lactamase inhibitor
Used for
- Complicated urinary tract infections, including kidney infections
- Complicated abdominal infections, combined with metronidazole
- Hospital-acquired pneumonia, including ventilator-associated pneumonia
Usual adult dose
IV every 8 hours: 1.5 g for urinary or abdominal infections; 3 g for hospital-acquired pneumonia. Lower doses with reduced kidney function.
Usual dose in children
Urinary or abdominal infections: 30 mg/kg combined medicine IV every 8 hours, maximum 1.5 g per dose. Age and kidney restrictions apply.
Common side effects
- Nausea and vomiting
- Diarrhea
- Headache
- Raised liver enzymes
Important warnings
- Contains ceftolozane and tazobactam, not tazobactam alone
- Serious allergic reactions possible, especially with previous beta-lactam antibiotic allergy
- Severe antibiotic-associated diarrhea may occur during or after treatment
- Kidney function determines dosing and requires monitoring
Pregnancy
Human pregnancy data are limited. Use requires weighing treatment benefits against potential risks.
Breastfeeding
Unknown whether ceftolozane or tazobactam enters human milk. Effects on breastfed infants are not established.
Interactions
- No clinically significant drug interactions are well established
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.